Avrobio's Incubator/Accelerator Round

Avrobio raised a round of funding on June 01, 2016. Investors include JLabs.

Avrobio (NASDAQ: AVRO) is a provider of lentiviral-based gene therapies. The company is focused on the development of its programs in Fabry disease and acute myeloid leukemia (AML), while actively bui…

Articles about Avrobio's Incubator/Accelerator Round: